Gold Royalty Vs. Novo Nordisk AS Industry Stock Comparison

Sell

37

GROY
Gold Royalty

Last Price:

$1.26

Seasonality Move:

2.35%

Sell

9

NONOF
Novo Nordisk AS

Last Price:

$86.80

Seasonality Move:

9.09%

Sell

37

Gold Royalty (GROY) is a Sell

Is Gold Royalty a Buy, Sell or Hold?

The current Gold Royalty [GROY] share price is $1.24. The Score for GROY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
GROY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

9

Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

The current Novo Nordisk AS [NONOF] share price is $85.04. The Score for NONOF is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
NONOF is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

GROY Stock Price Chart

What is Gold Royalty's stock price today?

The Gold Royalty share price today is $1.24

The current trend is relatively stagnant and GROY is experiencing slight buying pressure.

NONOF Stock Price Chart

What is Novo Nordisk AS's stock price today?

The Novo Nordisk AS share price today is $85.04

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight selling pressure.

GROY Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.02	Sell
Relative Strength Index (14 RSI):	50	Sell
Chaikin Money Flow:	147922	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.19 - 1.27)	Buy
Bollinger Bands (100):	(1.24 - 1.42)	Sell

NONOF Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-6.19	Sell
Relative Strength Index (14 RSI):	32.42	Sell
Chaikin Money Flow:	-1041	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(86.31 - 109.25)	Sell
Bollinger Bands (100):	(99.35 - 129.37)	Sell

GROY Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.22	Buy
20-day SMA:	1.22	Buy
50-day SMA:	1.29	Sell
200-day SMA:	1.49	Sell
8-day EMA:	1.22	Buy
20-day EMA:	1.23	Buy
50-day EMA:	1.27	Sell
200-day EMA:	1.43	Sell

NONOF Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	85.85	Sell
20-day SMA:	94.98	Sell
50-day SMA:	102.41	Sell
200-day SMA:	123.63	Sell
8-day EMA:	86.44	Sell
20-day EMA:	92.43	Sell
50-day EMA:	101.51	Sell
200-day EMA:	114.69	Sell

Gold Royalty Earnings Growth & GROY Earnings Dates

Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.09 per share.

Novo Nordisk AS Earnings Growth & NONOF Earnings Dates

Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.

Gold Royalty Technical Analysis

	Dec 24	Dec 26	Dec 27	Dec 30	Dec 31	Jan 2	Jan 3	Jan 6	Jan 7	Jan 8
	Dec						Jan
	24	26	27	30	31	02	03	06	07	08
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

	Dec 24	Dec 26	Dec 27	Dec 30	Dec 31	Jan 2	Jan 3	Jan 6	Jan 7	Jan 8
	Dec						Jan
	24	26	27	30	31	02	03	06	07	08
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):